Evidence map›Paper›PMID 40585404›Full record

ArticleFrontiers in digital health2025

An AI-based module for interstitial glucose forecasting enabling a "Do-It-Yourself" application for people with type 1 diabetes.

Antonio J Rodriguez-Almeida, Guillermo V Socorro-Marrero, Carmelo Betancort, Garlene Zamora-Zamorano, Alejandro Deniz-Garcia, María L Álvarez-Malé, Eirik Årsand, Cristina Soguero-Ruiz, Ana M Wägner, Conceição Granja and 2 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antonio J Rodriguez-AlmeidaInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.
Guillermo V Socorro-MarreroInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.
Carmelo BetancortEndocrinology and Nutrition Department, Complejo Hospitalario Universitario Insular Materno-Infantil, CHUIMI, Las Palmas de Gran Canaria, Spain.
Garlene Zamora-ZamoranoInstituto de Investigaciones Biomédicas y Sanitarias, University of de Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.
Alejandro Deniz-GarciaEndocrinology and Nutrition Department, Complejo Hospitalario Universitario Insular Materno-Infantil, CHUIMI, Las Palmas de Gran Canaria, Spain.
María L Álvarez-MaléInstituto de Investigaciones Biomédicas y Sanitarias, University of de Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.
Eirik ÅrsandDepartment of Computer Science, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Cristina Soguero-RuizDepartment of Signal Theory and Communications, Telematics and Computing Systems, Rey Juan Carlos University, URJC, Fuenlabrada, Spain.
Ana M WägnerEndocrinology and Nutrition Department, Complejo Hospitalario Universitario Insular Materno-Infantil, CHUIMI, Las Palmas de Gran Canaria, Spain.
Conceição GranjaNorwegian Centre for E-health Research, University Hospital of North-Norway, UNN, Tromsø, Norway.
Gustavo M CallicoInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.
Himar FabeloInstitute for Applied Microelectronics, University of Las Palmas de Gran Canaria, ULPGC, Las Palmas de Gran Canaria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetes mellitus (DM) is a chronic condition defined by increased blood glucose that affects more than 500 million adults. Type 1 diabetes (T1D) needs to be treated with insulin. Keeping glucose within the desired range is challenging. Despite the advances in the mHealth field, the appearance of the do-it-yourself (DIY) tools, and the progress in glucose level prediction based on deep learning (DL), these tools fail to engage the users in the long-term. This limits the benefits that they could have on the daily T1D self-management, specifically by providing an accurate prediction of their short-term glucose level. Methods: This work proposed a DL-based DIY framework for interstitial glucose prediction using continuous glucose monitoring (CGM) data to generate one personalized DL model per user, without using data from other people. The DIY module reads the CGM raw data (as it would be uploaded by the potential users of this tool), and automatically prepares them to train and validate a DL model to perform glucose predictions up to one hour ahead. For training and validation, 1 year of CGM data collected from 29 subjects with T1D were used. Results and Discussion: Results showed prediction performance comparable to the state-of-the-art, using only CGM data. To the best of our knowledge, this work is the first one in providing a DL-based DIY approach for fully personalized glucose prediction. Moreover, this framework is open source and has been deployed in Docker, enabling its standalone use, its integration on a smartphone application, or the experimentation with novel DL architectures.

Indexed as

continuous glucose monitoringdeep learningmHealthpersonalized medicinetype 1 diabetes

Identifiers

PMID40585404
PMCPMC12202434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.